Abstract | OBJECTIVES: METHODS: RESULTS:
Bleeding occurred in 21 patients (12 in the fondaparinux group and 9 in low molecular weight heparin group, respectively). No significant differences were detected in the incidence of postoperative bleeding and the other adverse events between the two groups. The D-dimer was elevated on postoperative day 1 in one patient (16.6 μg/mL). In another patient, the soluble fibrin monomer complex was elevated (109 μg/mL). CONCLUSIONS:
|
Authors | Kenichi Hata, Takahiro Kimura, Shunsuke Tsuzuki, Gen Ishii, Masahito Kido, Toshihiro Yamamoto, Hiroshi Sasaki, Jun Miki, Hiroki Yamada, Akira Furuta, Kenta Miki, Shin Egawa |
Journal | International journal of urology : official journal of the Japanese Urological Association
(Int J Urol)
Vol. 23
Issue 11
Pg. 923-928
(11 2016)
ISSN: 1442-2042 [Electronic] Australia |
PMID | 27545448
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Copyright | © 2016 The Japanese Urological Association. |
Chemical References |
- Anticoagulants
- Polysaccharides
- Heparin
- Fondaparinux
|
Topics |
- Anticoagulants
(therapeutic use)
- Fondaparinux
- Heparin
(therapeutic use)
- Humans
- Polysaccharides
(therapeutic use)
- Postoperative Complications
- Prospective Studies
- Single-Blind Method
- Urologic Neoplasms
(surgery)
- Venous Thromboembolism
(prevention & control)
|